BillionToOne Inc
NASDAQ:BLLN
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
B
|
BillionToOne Inc
NASDAQ:BLLN
|
4B USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
98.2B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
65.4B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
76.2B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
29.3B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24.2B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.3B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.3B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.4B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.1B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
BillionToOne Inc
Glance View
BillionToOne Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Menlo Park, California. The company went IPO on 2025-11-06. BillionToOne Inc is a United States-based precision diagnostics company. The firm provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and detect risk for common and severe genetic diseases. The Company’s product UNITY, is a noninvasive prenatal screening that tests fetal cell-free DNA for cystic fibrosis (CF) and spinal muscular atrophy (SMA) through a single sample of the mother's blood.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for BillionToOne Inc is 61%, which is in line with its 3-year median of 61%.
Over the last 0 months, BillionToOne Inc’s Gross Margin has decreased from 61% to 61%. During this period, it reached a low of 61% on Sep 30, 2025 and a high of 61% on Sep 30, 2025.
